K.-D. Schulz

804 total citations
31 papers, 634 citations indexed

About

K.-D. Schulz is a scholar working on Oncology, Cancer Research and Reproductive Medicine. According to data from OpenAlex, K.-D. Schulz has authored 31 papers receiving a total of 634 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 7 papers in Cancer Research and 6 papers in Reproductive Medicine. Recurrent topics in K.-D. Schulz's work include Global Cancer Incidence and Screening (5 papers), Breast Cancer Treatment Studies (5 papers) and Hypothalamic control of reproductive hormones (4 papers). K.-D. Schulz is often cited by papers focused on Global Cancer Incidence and Screening (5 papers), Breast Cancer Treatment Studies (5 papers) and Hypothalamic control of reproductive hormones (4 papers). K.-D. Schulz collaborates with scholars based in Germany, United States and Finland. K.-D. Schulz's co-authors include Günter Emons, Olaf Ortmann, Veronika Müller, Jürgen Hofmann, Uwe Wagner, Michael Koller, O. Hars, G. Emons, Eberhard Standl and Randy S. Roth and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, Endocrinology and American Journal of Obstetrics and Gynecology.

In The Last Decade

K.-D. Schulz

29 papers receiving 608 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
K.-D. Schulz Germany 15 170 169 160 140 137 31 634
V. Facchini Italy 14 84 0.5× 281 1.7× 224 1.4× 117 0.8× 64 0.5× 33 772
Peggy Wan United States 15 325 1.9× 117 0.7× 377 2.4× 102 0.7× 116 0.8× 22 971
Valentina Elisabetta Bounous Italy 18 176 1.0× 181 1.1× 278 1.7× 55 0.4× 199 1.5× 43 858
Bin Nan United States 11 90 0.5× 115 0.7× 56 0.3× 181 1.3× 175 1.3× 21 633
F Kuttenn France 12 421 2.5× 107 0.6× 167 1.0× 238 1.7× 296 2.2× 46 914
Michaela Onstad United States 10 83 0.5× 145 0.9× 304 1.9× 158 1.1× 31 0.2× 24 736
Angela Bowman United Kingdom 12 108 0.6× 110 0.7× 118 0.7× 92 0.7× 37 0.3× 16 407
Isabelle Coupier France 14 274 1.6× 47 0.3× 96 0.6× 255 1.8× 231 1.7× 35 834
Nicoletta Ravarino Italy 11 83 0.5× 62 0.4× 244 1.5× 54 0.4× 111 0.8× 25 517
Julian Peto United Kingdom 13 231 1.4× 47 0.3× 523 3.3× 462 3.3× 228 1.7× 15 1.1k

Countries citing papers authored by K.-D. Schulz

Since Specialization
Citations

This map shows the geographic impact of K.-D. Schulz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by K.-D. Schulz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites K.-D. Schulz more than expected).

Fields of papers citing papers by K.-D. Schulz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by K.-D. Schulz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by K.-D. Schulz. The network helps show where K.-D. Schulz may publish in the future.

Co-authorship network of co-authors of K.-D. Schulz

This figure shows the co-authorship network connecting the top 25 collaborators of K.-D. Schulz. A scholar is included among the top collaborators of K.-D. Schulz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with K.-D. Schulz. K.-D. Schulz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Schnitzler, Paul, et al.. (2010). Molecular analysis of linezolid resistance in clinical Enterococcus faecium isolates by polymerase chain reaction and pyrosequencing. European Journal of Clinical Microbiology & Infectious Diseases. 30(1). 121–125. 5 indexed citations
3.
Albert, Ute‐Susann, Michael Koller, Uwe Wagner, & K.-D. Schulz. (2004). Survival chances and psychological aspects of quality of life in patients with localized early stage breast cancer. Inflammation Research. 53(S2). S136–41. 19 indexed citations
4.
Albert, Ute‐Susann & K.-D. Schulz. (2003). Mammakarzinom. Der Gynäkologe. 36(9). 753–760. 1 indexed citations
5.
Engel, Jutta, Gabriele Nagel, Eun‐Kyoung Breuer, et al.. (2002). Primary breast cancer therapy in six regions of Germany. European Journal of Cancer. 38(4). 578–585. 33 indexed citations
6.
Hadji, Peyman, et al.. (2000). Assessment by quantitative ultrasonometry of the effects of hormone replacement therapy on bone mass. American Journal of Obstetrics and Gynecology. 182(3). 529–534. 16 indexed citations
7.
Hadji, Peyman, et al.. (2000). Quantitative Ultrasound of Os Calcis in Postmenopausal Women with Spine and Hip Fractures. Journal of Clinical Densitometry. 3(3). 233–239. 22 indexed citations
8.
Hadji, Peyman, O. Hars, Karin Bock, et al.. (1999). Age Changes of Calcaneal Ultrasonometry in Healthy German Women. Calcified Tissue International. 65(2). 117–120. 27 indexed citations
9.
O’Higgins, N. J., Dimitrios Linos, M Blichert-Toft, et al.. (1998). European guidelines for quality assurance in the surgical management of mammographically detected lesions. European Breast Cancer Working Group.. PubMed. 87(1). 110–2. 16 indexed citations
10.
O’Higgins, N. J., M Blichert-Toft, Luigi Cataliotti, et al.. (1998). European guidelines for quality assurance in the surgical management of mammographically detected lesions. European Journal of Surgical Oncology. 24(2). 96–98. 37 indexed citations
11.
Emons, Günter, Veronika Müller, Olaf Ortmann, & K.-D. Schulz. (1998). Effects of LHRH-analogues on mitogenic signal transduction in cancer cells. The Journal of Steroid Biochemistry and Molecular Biology. 65(1-6). 199–206. 118 indexed citations
12.
Duda, Volker, et al.. (1998). Ductal orientated sonography improves the diagnosis of pathological nipple discharge of the female breast compared with galactography. European Journal of Cancer Prevention. 7. S57–S62. 18 indexed citations
13.
Hannig, K., et al.. (1996). Androgen-like and anti-androgen-like effects of antiprogestins in human mammary cancer cells. European Journal of Cancer. 32(4). 696–701. 14 indexed citations
14.
Ortmann, Olaf, Kevin Catt, K.-D. Schulz, & Günter Emons. (1994). Modulatory action of progesterone and progesterone antagonists on hypothalamic-pituitary function. Human Reproduction. 9(suppl 1). 53–62. 4 indexed citations
15.
Schulz, K.-D., et al.. (1994). Urinary excretion of growth factors in patients with ovarian cancer. European Journal of Cancer. 30(12). 1851–1858. 12 indexed citations
16.
Emons, Günter, Olaf Ortmann, G. S. Pahwa, F Oberheuser, & K.-D. Schulz. (1992). LH-RH Agonists in the Treatment of Ovarian Cancer. Recent results in cancer research. 124. 55–68. 5 indexed citations
17.
18.
Kußmann, J., et al.. (1991). Symptomatik eines rupturierten Leberhämatoms als schwere Komplikation des HELLP-Syndroms. Geburtshilfe und Frauenheilkunde. 51(4). 313–314. 1 indexed citations
19.
Hackenberg, Reinhard, et al.. (1990). Down-regulation of androgen receptor by progestins and interference with estrogenic or androgenic stimulation of mammary carcinoma cell growth. Journal of Cancer Research and Clinical Oncology. 116(5). 492–498. 17 indexed citations
20.
Hofmann, Jürgen, et al.. (1988). Stimulatory effects of androgen and antiandrogen on the in vitro proliferation of human mammary carcinoma cells. Journal of Cancer Research and Clinical Oncology. 114(6). 593–601. 37 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026